The Safety and Efficacy Study of Vemurafenib (CT) Compared With Vemurafenib (Zelbolaf®) in Advanced Patients Harboring the V600 BRAF Mutation

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2015
This article has no abstract
Epistemonikos ID: 03f14d485f5282d7d0b092cf6df3e02b4922acf2
First added on: Apr 17, 2025